Clinical trial
VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target
NCT04259138 is registered in ClinicalTrials.gov with Alimentiv Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target
- Lead sponsor
- Alimentiv Inc.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 18, 2020
- Completion date
- April 13, 2026
- Enrollment
- 672 (actual)
- Sites
- 58
Conditions
As the registry lists them; a condition with its own page is linked.